Association of IRF(4) single-nucleotide polymorphism rs12203592 with melanoma-specific survival Correspondence

   

Authors:	Ward, S. V.; Gibbs, D. C.; Orlow, I.; Thomas, N. E.; Kanetsky, P. A.; Luo, L.; Cust, A. E.; Anton-Culver, H.; Gruber, S. B.; Gallagher, R. P.; Rosso, S.; Zanetti, R.; Dwyer, T.; Begg, C. B.; Berwick, M.; and on behalf of the GEM Study Group
Title:	Association of IRF(4) single-nucleotide polymorphism rs12203592 with melanoma-specific survival
Keywords:	single nucleotide polymorphism; histopathology; cancer risk; united states; follow up; cancer diagnosis; letter; melanoma; melanocyte; genotype; genetic variation; immunoregulation; immune response; blood sampling; australia; tumor growth; canada; cause specific survival; interferon regulatory factor 4; italy; cancer prognosis; breslow thickness; western australia; human; priority journal
Journal Title:	British Journal of Dermatology
Volume:	183
Issue:	1
ISSN:	0007-0963
Publisher:	Blackwell Publishing
Date Published:	2020-07-01
Start Page:	163
End Page:	165
Language:	English
DOI:	10.1111/bjd.18881
PUBMED:	31958143
PROVIDER:	scopus
PMCID:	PMC7334062
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079845382&doi=10.1111%2fbjd.18881&partnerID=40&md5=470fa469f9ad52ed7c75518e84d790ad
Notes:	Letter -- Export Date: 3 August 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/168654